About
Novo Nordisk Fonden is an independent Danish commercial foundation that supports scientific, humanitarian and social purposes. The foundation's vision is to promote human health and the sustainability of society and the planet. The foundation supports a wide range of projects and initiatives across three focus areas: health, sustainability, and the life science ecosystem. It provides both competitive grants and strategic initiatives, and distributes awards for scientific research and education.
Funding Opportunities
Project Grants in Clinical and Translational Medicine
The objective of this call is to broadly promote Danish clinical or translational research of high international level. The research should involve patients/humans and/or clinical practice, diagnostic or therapeutic methods, but can also involve established animal models. The Foundation provides grants to support research activities that must be anchored at a university, hospital or other non-profit research institution in Denmark. A total of up to DKK 76 million is available for projects lasting from 1-3 years, with individual grants of up to DKK 4,400,000 million and a yearly maximum budget of DKK 1,480,000 million. DKK 11 million are specifically earmarked for projects within the strategic focused theme 'Interactions between infectious diseases and cardiometabolic diseases', aimed at improving understanding of the dual-burden and interactions between infectious diseases and cardiometabolic diseases.
Investigator Initiated Clinical Trials
The Novo Nordisk Foundation provides grants to strengthen opportunities for conducting larger clinical trials in Denmark without commercial purpose. The ultimate objective is to improve patient treatment through new medicine and technology and ensure the highest quality in treatment. Grants support both monocentric and multicenter national trials. For multicenter international clinical trials, the coordinating investigator and trial must be anchored at a Danish hospital. Clinical trials must conform to good clinical practice guidelines (GCP), demonstrate clinical relevance and scientific quality, and include detailed protocols with power calculations, data management plans, and statistical analysis plans. Randomized controlled trials are preferred, though nonrandomized trials are also accepted. All funded trials must be registered at ClinicalTrials.gov or the Clinical Trials Information System (CTIS), and anonymized data must be made publicly available upon completion.
Novonesis Biotechnology Prize
The Novonesis Biotechnology Prize is awarded annually to recognize outstanding European research or technology achievements that contribute to the development of innovative and sustainable biotechnology solutions for the benefit of people and the planet. The Prize raises awareness of basic and applied biotechnology research in areas such as biomanufacturing, industrial, environmental, food, or plant biotechnology. The Prize consists of a funding amount for the awardee's research (DKK 4.5 million), a personal award (DKK 0.5 million), and an international symposium within the awardee's field of research. The award is made through a nomination process by a prize committee after a confidential review of nominees who have made important contributions to European Science with a current position and active research program at a public or non-profit research institution in Europe.
At a Glance
- Total Funding Opportunities
- 30
- Active Now
- 3
- Source Domain
- novonordiskfonden.dk
Catalog Data
This funder profile was automatically extracted from grant listings. Information may be incomplete.
Visit official website